Research
Press
January 21, 2026
October 9, 2025

Low phase angle (PA) measured via the Bodyport Cardiac Scale is strongly associated with a higher risk of hospitalization in heart failure patients

With this research, we demonstrate that phase angle (a metric measured by the Bodyport Cardiac Scale) was independently associated with HF hospitalization risk. Read more here.

Bodyport develops remote monitoring technologies for patients with fluid management-related health conditions. The FDA-cleared Bodyport Cardiac Scale measures weight, peripheral impedance, pulse rate, and balance through a simple daily measurement. Bodyport’s clinician-facing software combines longitudinal data into the Congestion Index, a clinical decision support tool that helps healthcare professionals identify and evaluate changes associated with worsening congestion.Based in San Francisco, the company is backed by top-tier investors including Boehringer Ingelheim Venture Fund, Terumo Medical, Initialized Capital, Playground Global, Rock Health, and Y Combinator. For more information, visit bodyport.com and follow the company on LinkedIn and Twitter.